A doctor examining a patient
A doctor examining a patient

ICML 2023

ICML 2023

13 - 17

Jun 2023

ICML 2023

Lugano, Switzerland
Congress website

Bi-yearly meeting addressing the state-of-the-art on the biology, pathology and management of lymphoid neoplasms.

  • Poster

    Five-year efficacy and safety of tafasitamab in patients with relapsed or refractory DLBCL: Final results from the Phase II L-MIND study

  • Poster

    Five-year Subgroup Analysis Of Tafasitamab + Lenalidomide From The Phase II L-MIND Study In Patients With Relapsed Or Refractory Diffuse Large B-cell Lymphoma

AACR 2023

Annual meeting highlighting cancer research from institutions worldwide.

14/04 - 19/04 Orlando, FL
LEARN MORE

ASCO 2023

Annual meeting featuring presentations on the latest research in cancer care.

02/06 - 06/06 Chicago, IL
LEARN MORE

EHA 2023

European-based organization and congress promoting excellence in hematology.

08/06 - 11/06 Frankfurt, Germany
LEARN MORE

MorphoSys is providing the data presented at medical congresses as part of scientific exchange. The scientific information may include data/information on investigational use(s) of compounds/drugs of which the efficacy and safety have not yet been established. Information available on this website is not intended to promote or otherwise commercialize (directly or indirectly) any off-label or unapproved uses of MorphoSys’ products. Copies of congress presentations may not be reproduced without written permission from the congress and the authors.